Abstract
In early life, patients with sickle cell disease (SCD) can have acute, life-threatening emergencies related to splenic hypofunction (overwhelming bacterial sepsis), as well as anemic crises from acute splenic sequestration because of sudden pooling of blood in the spleen. The landmark penicillin prophylaxis study in 1985 showed a remarkable decrease in mortality from sepsis in young children with SCD who were treated with oral penicillin prophylaxis compared to placebo. Since that study, newborns are screened for SCD and placed on oral penicillin prophylaxis in nearly all of the United States, as well as in other countries where the disease is highly prevalent. The previously described permanent, complete and nearly universal “autosplenectomy” emerging by late childhood or early adulthood is now challenged by recent findings of reversibility of splenic dysfunction by the antisickling drug hydroxyurea or by successful allogeneic stem cell transplantation, even in older patients. Imaging techniques for hypofunction of the spleen are the most commonly used modalities to guide the clinician in decisions regarding medical or surgical management.
Similar content being viewed by others
References
Herrick JB (2001) Peculiar elongated and sickle-shaped red blood corpuscles in a case of severe anemia. 1910. Yale J Biol Med 74:179–184
Pauling L, Itano HA, Singer SJ et al (1949) Sickle cell anemia, a molecular disease. Science 110:543–548
Ataga KI, Cappellini MD, Rachmilewitz EA (2007) Beta-thalassaemia and sickle cell anaemia as paradigms of hypercoagulability. Br J Haematol 139:3–13
Ataga KI, Key NS (2007) Hypercoagulability in sickle cell disease: new approaches to an old problem. Hematology Am Soc Hematol Educ Program 2007:91–96
Ataga KI, Orringer EP (2003) Hypercoagulability in sickle cell disease: a curious paradox. Am J Med 115:721–728
Onwubalili JK (1983) Sickle cell disease and infection. J Infect 7:2–20
Overturf G, Powars D (1980) Infections in sickle cell anemia: pathogenesis and control. Tex Rep Biol Med 40:283–292
William BM, Corazza GR (2007) Hyposplenism: a comprehensive review. Part I: basic concepts and causes. Hematology 12:1–13
Pearson HA, Spencer RP, Cornelius EA (1969) Functional asplenia in sickle-cell anemia. N Engl J Med 281:923–926
Dickerhoff R (2002) Splenic sequestration in patients with sickle cell disease. Klin Padiatr 214:70–73
Benjamin JT, McMillan CW, Komp DM (1979) Fatal splenic sequestration crisis. Va Med 106:679–680
Walterspiel JN, Rutledge JC, Bartlett BL (1984) Fatal acute splenic sequestration at 4 months of age. Pediatrics 73:507–508
Emond AM, Collis R, Darvill D et al (1985) Acute splenic sequestration in homozygous sickle cell disease: natural history and management. J Pediatr 107:201–206
Grover R, Wethers DL (1990) Management of acute splenic sequestration crisis in sickle cell disease. J Assoc Acad Minor Phys 1:67–70
Al-Salem AH, Naserullah Z, Qaisaruddin S et al (1999) Splenic complications of the sickling syndromes and the role of splenectomy. J Pediatr Hematol Oncol 21:401–406
Delatte SJ, Hebra A, Tagge EP et al (1999) Acute chest syndrome in the postoperative sickle cell patient. J Pediatr Surg 34:188–191; discussion 191–192
Giebink GS, Le CT, Schiffman G (1984) Decline of serum antibody in splenectomized children after vaccination with pneumococcal capsular polysaccharides. J Pediatr 105:576–582
Wethers DL, Grover R (1987) Reversibility of splenic function by transfusion in two young adults with sickle cell anemia. Am J Pediatr Hematol Oncol 9:209–211
Pearson HA, Cornelius EA, Schwartz AD et al (1970) Transfusion-reversible functional asplenia in young children with sickle-cell anemia. N Engl J Med 283:334–337
Buchanan GR, McKie V, Jackson EA et al (1989) Splenic phagocytic function in children with sickle cell anemia receiving long-term hypertransfusion therapy. J Pediatr 115:568–572
Koren A, Haasz R, Tiatler A et al (1984) Serum immunoglobulin levels in children after splenectomy. A prospective study. Am J Dis Child 138:53–55
Shatney CH (1987) Complications of splenectomy. Acta Anaesthesiol Belg 38:333–339
Barrett DJ, Ammann AJ (1981) Pneumococcal vaccine in sickle cell disease: IgG and IgM antibody response. Rev Infect Dis 3 [Suppl]:S179–S182
Risdon RA, Barry M, Flynn DM (1975) Transfusional iron overload: the relationship between tissue iron concentration and hepatic fibrosis in thalassaemia. J Pathol 116:83–95
Campbell PJ, Olatunji PO, Ryan KE et al (1997) Splenic regrowth in sickle cell anaemia following hypertransfusion. Br J Haematol 96:77–79
Wright JG, Hambleton IR, Thomas PW et al (1999) Postsplenectomy course in homozygous sickle cell disease. J Pediatr 134:304–309
Vichinsky E, Pakbaz Z, Onyekwere O et al (2008) Patient-reported outcomes of deferasirox (Exjade, ICL670) versus deferoxamine in sickle cell disease patients with transfusional hemosiderosis. Substudy of a randomized open-label phase II trial. Acta Haematol 119:133–141
Wood JC, Ghurge N (2008) Magnetic resonance imaging assessment of excess iron in thalassemia, sickle cell disease and other iron overload diseases. Hemoglobin 32:85–96
Positano V, Salani B, Pepe A et al (2008) Improved T2* assessment in liver iron overload by magnetic resonance imaging. Magn Reson Imaging (in press) doi:10.1016/j.mri.2008.06.004
Walker TM, Serjeant GR (1993) Focal echogenic lesions in the spleen in sickle cell disease. Clin Radiol 47:114–116
Levin TL, Berdon WE, Haller JO et al (1996) Intrasplenic masses of “preserved” functioning splenic tissue in sickle cell disease: correlation of imaging findings (CT, ultrasound, MRI, and nuclear scintigraphy). Pediatr Radiol 26:646–649
Casper JT, Koethe S, Rodey GE et al (1976) A new method for studying splenic reticuloendothelial dysfunction in sickle cell disease patients and its clinical application: a brief report. Blood 47:183–188
Santos A, Pinheiro V, Anjos C et al (2002) Scintigraphic follow-up of the effects of therapy with hydroxyurea on splenic function in patients with sickle cell disease. Eur J Nucl Med Mol Imaging 29:536–541
Hankins JS, Helton KJ, McCarville MB et al (2008) Preservation of spleen and brain function in children with sickle cell anemia treated with hydroxyurea. Pediatr Blood Cancer 50:293–297
Wang WC, Wynn LW, Rogers ZR et al (2001) A two-year pilot trial of hydroxyurea in very young children with sickle-cell anemia. J Pediatr 139:790–796
Claster S, Vichinsky E (1996) First report of reversal of organ dysfunction in sickle cell anemia by the use of hydroxyurea: splenic regeneration. Blood 88:1951–1953
Olivieri NF, Vichinsky EP (1998) Hydroxyurea in children with sickle cell disease: impact on splenic function and compliance with therapy. J Pediatr Hematol Oncol 20:26–31
Ferster A, Bujan W, Corazza F et al (1993) Bone marrow transplantation corrects the splenic reticuloendothelial dysfunction in sickle cell anemia. Blood 81:1102–1105
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Khatib, R., Rabah, R. & Sarnaik, S.A. The spleen in the sickling disorders: an update. Pediatr Radiol 39, 17–22 (2009). https://doi.org/10.1007/s00247-008-1049-9
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00247-008-1049-9